Difficulty: Medium
Average Score: 90%
Practice
Select the correct statement in relation to drug therapy of migraine
Correct answer
C
Rationale
In the context of drug therapy for migraine, option C, which states "Use of ergot alkaloids is restricted to severe or resistant cases," is the correct statement. Ergot alkaloids, such as ergotamine, are indeed reserved for cases of severe or refractory migraines due to their potent vasoconstrictive effects and potential for serious side effects.
Option A, stating that simple analgesics like paracetamol are ineffective in migraine, is incorrect. While simple analgesics may not be sufficient for severe migraines, they can be effective for mild to moderate episodes in many individuals.
Option B, claiming that ergot alkaloids are used for both prophylaxis and acute treatment of migraine attacks, is incorrect. Ergot alkaloids are generally not recommended for prophylaxis due to their side effect profile and the availability of safer and more effective prophylactic medications.
Option D, suggesting that ergot alkaloids should be continued for 24 hours after an attack has subsided, is also incorrect. Prolonged use of ergot alkaloids can increase the risk of medication-overuse headaches and other adverse effects.
It is crucial for healthcare providers to have a good understanding of the appropriate use of medications for migraines to ensure optimal patient outcomes. Educating patients about the different treatment options available, their indications, and potential side effects is essential for effective management of migraine headaches.
Option A, stating that simple analgesics like paracetamol are ineffective in migraine, is incorrect. While simple analgesics may not be sufficient for severe migraines, they can be effective for mild to moderate episodes in many individuals.
Option B, claiming that ergot alkaloids are used for both prophylaxis and acute treatment of migraine attacks, is incorrect. Ergot alkaloids are generally not recommended for prophylaxis due to their side effect profile and the availability of safer and more effective prophylactic medications.
Option D, suggesting that ergot alkaloids should be continued for 24 hours after an attack has subsided, is also incorrect. Prolonged use of ergot alkaloids can increase the risk of medication-overuse headaches and other adverse effects.
It is crucial for healthcare providers to have a good understanding of the appropriate use of medications for migraines to ensure optimal patient outcomes. Educating patients about the different treatment options available, their indications, and potential side effects is essential for effective management of migraine headaches.